PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 82 filers reported holding PLIANT THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $542,690 | -22.5% | 31,297 | -19.0% | 0.00% | 0.0% |
Q2 2023 | $700,030 | -22.0% | 38,633 | +14.5% | 0.00% | -33.3% |
Q1 2023 | $897,351 | +26.7% | 33,735 | -8.0% | 0.00% | +50.0% |
Q4 2022 | $708,522 | +13.2% | 36,654 | -53.1% | 0.00% | 0.0% |
Q2 2022 | $626,000 | +103.2% | 78,200 | +78.1% | 0.00% | +100.0% |
Q1 2022 | $308,000 | +55.6% | 43,900 | +198.6% | 0.00% | – |
Q4 2021 | $198,000 | -20.2% | 14,700 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $248,000 | -42.1% | 14,700 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $428,000 | -26.0% | 14,700 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $578,000 | +73.1% | 14,700 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $334,000 | – | 14,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |